These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4146878)

  • 41. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
    Jain M; Bakutis E; Gayle T; Lansky P
    Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 45. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of monoamine oxidase inhitors on M-serotonin reactive structures of the superior cervical ganglion in cats].
    Gilëv AP; Kurilenko VM
    Farmakol Toksikol; 1966; 29(6):665-8. PubMed ID: 6000362
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hydrazine derivative modification of the activity of brain mitochondrial monoamine oxidases].
    Kalninia IE; Baumanas EA; Kaĭrane ChB; Gorkin VZ
    Vopr Med Khim; 1981; 27(6):773-9. PubMed ID: 7336653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circadian rhythm in the serotonin content of the rat pineal gland: regulating factors.
    Snyder SH; Axelrod J; Zweig M
    J Pharmacol Exp Ther; 1967 Nov; 158(2):206-13. PubMed ID: 4383637
    [No Abstract]   [Full Text] [Related]  

  • 49. Physicochemical properties, development, and regulation of central and peripheral monoamine oxidase activity.
    Youdim MB; Holzbauer M; Woods HF
    Adv Biochem Psychopharmacol; 1974; 12(0):11-28. PubMed ID: 4608303
    [No Abstract]   [Full Text] [Related]  

  • 50. [Heterocyclic amine derivatives - analogs of mebanazine, pheniprazine and phenelzine. II. Studies on the effect, on the central nervous system, of derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine, perhydro-1,5-oxazocine and morpholine-containing arylalkyloamine groups].
    Szadowska A; Mazur M; Szmigielski A; Szmigielska H; Winer A
    Acta Pol Pharm; 1983; 40(1):111-8. PubMed ID: 6136156
    [No Abstract]   [Full Text] [Related]  

  • 51. [Histochemical study of the action in vitro of serotonin, of tryptamine and some of their derivatives on rat brain monoamine oxidases].
    Boucaud J; Bouchaud C; Couteaux R
    C R Acad Hebd Seances Acad Sci D; 1967 Jan; 264(5):775-8. PubMed ID: 4989210
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of 3,12-B-dimethyloctahydroindolo-(2,3-a)-quinolyzine on the alcohol predilection of laboratory animals].
    Borisov MM; Mufazalova TP; Safrazbekian RR; Arzanunts EM; Sukasian RS
    Farmakol Toksikol; 1986; 49(4):95-7. PubMed ID: 3758341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 55. Discriminant analysis of the relationship between physical properties and the inhibition of monoamine oxidase by aminotetralins and aminoindans.
    Martin YC; Holland JB; Jarboe CH; Plotnikoff N
    J Med Chem; 1974 Apr; 17(4):409-13. PubMed ID: 4830537
    [No Abstract]   [Full Text] [Related]  

  • 56. Monoamine oxidase inhibitory and anticonvulsant properties of some newer indolylimidazolones.
    Mehrotra S; Dhasmana A; Gupta TK; Parmar SS; Barthwal JP
    Res Commun Chem Pathol Pharmacol; 1987 Jun; 56(3):421-4. PubMed ID: 3628969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 58. [Derivatives of hydrazides and hydrazines inhibiting monoamine oxidase. Mechanisms cited to account for their pharmacological effects].
    LEVY J
    Actual Pharmacol (Paris); 1961; 14():125-73. PubMed ID: 14464772
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence that 5-methoxy-N, N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome.
    Squires RF
    J Neurochem; 1975 Jan; 24(1):47-50. PubMed ID: 1053788
    [No Abstract]   [Full Text] [Related]  

  • 60. THE EFFECT OF DIETHYLTRYPTAMINE AND ITS DERIVATIVES ON MONOAMINE OXIDASE.
    HUSZTI Z; BORSY J
    Biochem Pharmacol; 1964 Aug; 13():1151-6. PubMed ID: 14222512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.